Guided Therapeutics (GTHP) EBITDA (2009 - 2026)
Guided Therapeutics (GTHP) reported EBITDA of -$436,000 for Q2 2026, compared with -$692,000 a year earlier.
Analysis
Guided Therapeutics (GTHP) EBITDA (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Guided Therapeutics' EBITDA came in at -$1.77 million; for FY2025, it was -$2.12 million.
- By year, EBITDA came in at -$1.99 million in FY2024, -$3.32 million in FY2023, -$3.19 million in FY2022 and -$2.03 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$1.47 million in Q2 2023 and a high of $1.73 million in Q3 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$252,000 (Q1 2026), -$652,000 (Q4 2025) and -$429,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 3.09 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 2.61 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 1.97 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 789.70 Mn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 1.19 Bn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 344.00 Mn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 769.00 Mn |
| 10 | Guided Therapeutics | 10,618.96 | -520,381.04 | - | -436,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -436,000.00 |
| Mar 31, 2026 | -252,000.00 |
| Dec 31, 2025 | -652,000.00 |
| Sep 30, 2025 | -429,000.00 |
| Jun 30, 2025 | -692,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | -494,000.00 |
| Sep 30, 2024 | -537,000.00 |
| Jun 30, 2024 | -634,000.00 |
| Mar 31, 2024 | -325,000.00 |
| Dec 31, 2023 | -450,000.00 |
| Sep 30, 2023 | -589,000.00 |
| Jun 30, 2023 | -1.47 Mn |
| Mar 31, 2023 | -809,000.00 |
| Dec 31, 2022 | -913,000.00 |
| Sep 30, 2022 | -1.19 Mn |
| Jun 30, 2022 | -680,000.00 |
| Mar 31, 2022 | -402,000.00 |
| Dec 31, 2021 | -394,000.00 |
| Dec 31, 2020 | -167,000.00 |
API Access
Guided Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GTHP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();